DENTSPLY SIRONA (XRAY) to Release Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, May 8th. Analysts expect DENTSPLY SIRONA to post earnings of $0.30 per share and revenue of $854.75 million for the quarter.

DENTSPLY SIRONA Trading Down 3.4 %

NASDAQ:XRAY opened at $13.37 on Wednesday. The company has a market capitalization of $2.66 billion, a P/E ratio of -6.46, a PEG ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12 month low of $12.16 and a 12 month high of $29.13. The firm has a fifty day simple moving average of $14.42 and a 200-day simple moving average of $17.77.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.79%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.07%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on XRAY shares. Evercore ISI restated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho reduced their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Piper Sandler lowered their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.45.

Insider Buying and Selling

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.